Atopic dermatitis (AD) patients achieving minimal disease activity (MDA) based on both clinician and patient-reported outcomes had fewer flares, shorter flares, reduced healthcare resource utilization, and a higher rate of patient-reported disease control when compared with patients who met one or neither optimal target. Vimal Hasmukh Prajapati, MD, FRCPC, a Clinical Associate Professor at the University of Calgary and Co-founder/Co-director of the Skin Health & Wellness Centre, Dermphi Centre, Dermphi Shop, and the Dermatology Research Institute in Calgary, Alberta, Canada, shares the results of a new study on the MDA concept that was presented at the American Academy of Dermatology’s 2025 meeting.
